Vasomotor arterial endothelial dysfunction and hyperhomocysteinemia as diastolic heart failure progression risk factors in case of carbohydrate metabolism disorders

Cover Page

Abstract


Aim. To evaluate significance of hyperhomocysteinemia and arterial endothelial dysfunction in the progression of diastolic heart failure in case of carbohydrate metabolism disorders.

Methods. The study included 134 patients (63 men and 71 women), mean age - 59.3±4.7 years. The first group included patients with ischemic heart disease associated with type 2 diabetes mellitus (n=46). The second group included patients with type 2 diabetes mellitus and hypertension (n=48). The control group (n=40) included healthy volunteers without carbohydrate metabolism disorders and history of cardiovascular diseases.

Results. Homocysteine concentration was 19.7±5.2 mmol/l in patients with type 2 diabetes mellitus, and was significantly higher than in the control group - 10.77±3.9 mmol/l (p <0.001). Hyperhomocysteinemia was diagnosed in 38 (82.6%) patients of the first group, in 8 cases values were normal. Homocysteine above-limit values were diagnosed in 28 (58.3%) patients in the second group, in the control group hyperhomocysteinemia was observed in 6 (15%) patients. Vasomotor endothelial dysfunction was diagnosed in all patients with type 2 diabetes mellitus when evaluating the endothelial mechanism of vascular tone regulation: endothelium-dependent vasodilation of the brachial artery was 3.7±1.3% in the first group, in the second group - 7.3±2.1%, what is significantly lower compared with that in the control group - 12.3±2.2% (p <0.03). There was no increase in the brachial artery diameter in response to reactive hyperemia test in 30.4% of cases and abnormal vasoconstriction was observed in 10.9% of cases in the first group.

Conclusion. Endothelial dysfunction leads to failure of regulatory mechanisms, contributes to the formation and progression of cardiovascular events: myocardial ischemia and left ventricular diastolic dysfunction in patients with diabetes mellitus associated with the hyperglycemia and hyperhomocysteinemia.


A G Denisova

Penza Advanced Training Institute for Doctors, Penza, Russia

Author for correspondence.
Email: pozdnyakova-n-v@rambler.ru

I P Tatarchenko

Penza Advanced Training Institute for Doctors, Penza, Russia

Email: pozdnyakova-n-v@rambler.ru

N V Pozdnyakova

Penza Advanced Training Institute for Doctors, Penza, Russia; Medical and Sanitary Unit №59, Penza, Russia

Email: pozdnyakova-n-v@rambler.ru

O I Morozova

Penza Advanced Training Institute for Doctors, Penza, Russia

Email: pozdnyakova-n-v@rambler.ru

  1. Беленков Ю.Н., Мареев В.Ю. Лечение сердечной недостаточности в XXI веке: достижения, вопросы и уроки доказательной медицины. Кардиология. 2008; (2): 6-16.
  2. Дедов И.И. Сахарный диабет: развитие технологий в диагностике, лечении и профилактике. Сахарн. диабет. 2010; (3): 6-13.
  3. Дзяк Г.В., Коваль Е.А., Каплан П.А. Гипергомоцистеинемия и целесообразность её коррекции у больных ишемической болезнью сердца. Междунар. мед. ж. 2004; (1): 14-15.
  4. Намаканов В.А., Расулов М.М. Эндотелиальная дисфункция при артериальной гипертензии - фактор риска сердечно-сосудистых заболеваний. Кардиоваск. терап. и профил. 2005; (6): 98-101.
  5. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвёртый пересмотр). Сердечн. недостат. 2013; 7 (81): 379-472.
  6. Соболева Е.В., Лебедев П.А. Гомоцистеинемия в патогенезе ишемической болезни сердца. Плейотропные эффекты статинов. Вестн. СамГУ. Естественнонауч. серия. 2007; 2 (52): 242-255.
  7. Татарченко И.П., Позднякова Н.В., Морозова О.И., Секерко С.И. Диастолическая дисфункция левого желудочка при ишемической болезни сердца (патофизиологические, клинические и инструментальные аспекты, оптимизация терапии). Пенза. 2009; 142 с.
  8. Татарченко И.П., Денисова А.Г., Позднякова Н.В., Морозова О.И., Факторы риска сердечно-сосудистых нарушений при сахарном диабете 2-го типа. Международ. науч.-исслед. ж. Мед. науки. 2015; 7 (38): 57-59.
  9. Nagueh S.F., Appleton C.P., Gillebert T.C. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J. Am. Soc. Echocardiogr. 2009; 22: 107-133. http://dx.doi.org/10.1016/j.echo.2008.11.023
  10. Vanhecke T.E., Kim R., Raheem S.Z., McCullough P.A. Myocardial ischemia in patients with diastolic dysfunction and heart failure. Curr. Cardiol. Rep. 2010; 12: 216-222. http://dx.doi.org/10.1007/s11886-010-0101-1
  11. Zhou J., Werstuck G.H., Lhotak S. et al. Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice. FASEB J. 2008; 22 (7): 2569-2578. http://dx.doi.org/10.1096/fj.07-105353

Views

Abstract - 230

PDF (Russian) - 201

Cited-By


PlumX


© 2015 Denisova A.G., Tatarchenko I.P., Pozdnyakova N.V., Morozova O.I.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Свидетельство о регистрации СМИ ЭЛ № ФС 77-75008 от 1 февраля 2019 года выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор)


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies